Serum Institute Receives Approval To Launch Covovax Trials On Children Aged 7-11
Photo courtesy: Swarajyamag
Serum Institute of India has received permission to conduct clinical trials of Covovax among children aged 7 to 11 years.
According to reports, the SII-manufactured Novavax vaccine, Covovax, could be available for approval for use in children as early as January or February 2022.
Read more at: https://swarajyamag.com/news-brief/serum-institute-receives-approval-to-launch-covovax-trials-on-children-aged-7-11
- 30 Sep 2021